Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Engineered allergens for immunotherapy.

Prem L Bhalla1, Mohan B Singh

  • 1Plant Molecular Biology and Biotechnology Laboratory, Australian Research Council Centre of Excellence for Integrative Legume Research, Institute of Land and Food Resources, The University of Melbourne, Parkville, Victoria, Australia. premlb@unimelb.edu.au

Current Opinion in Allergy and Clinical Immunology
|January 11, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deciphering the Vulnerability of Pollen to Heat Stress for Securing Crop Yields in a Warming Climate.

Plant, cell & environment·2024
Same author

Identifying long non-coding RNAs involved in heat stress response during wheat pollen development.

Frontiers in plant science·2024
Same author

Overexpression of GmPIF4b affects morpho-physiological traits to reduce heat-induced grain loss in soybean.

Plant physiology and biochemistry : PPB·2023
Same author

Biological Parts for Engineering Abiotic Stress Tolerance in Plants.

Biodesign research·2023
Same author

Pokkali: A Naturally Evolved Salt-Tolerant Rice Shows a Distinguished Set of lncRNAs Possibly Contributing to the Tolerant Phenotype.

International journal of molecular sciences·2023
Same author

Circular RNAs modulate the floral fate acquisition in soybean shoot apical meristem.

BMC plant biology·2023

Genetically engineered hypoallergenic allergens offer a safer alternative to traditional immunotherapy for allergies. These modified allergens retain T-cell reactivity while reducing allergic reactions, paving the way for improved treatments.

Area of Science:

  • Allergen immunotherapy
  • Genetic engineering
  • Immunology

Background:

  • Specific immunotherapy is an effective treatment for allergies but uses crude natural extracts with risks of anaphylaxis.
  • Molecular cloning of allergens enables the development of safer, engineered therapeutic agents.
  • Recent advances focus on genetic modification of allergens for improved immunotherapy.

Purpose of the Study:

  • To review recent advances (last 2 years) in genetic engineering of allergens for specific immunotherapy.
  • To explore novel therapeutic approaches for safer and more effective allergen-specific immunotherapy.

Main Methods:

  • Genetic engineering of allergens to reduce IgE binding sites.
  • Preserving T-cell reactivity in modified allergens.

Related Experiment Videos

  • Developing hypoallergenic forms of major allergens.

    • Main Results:

    • Genetically engineered allergens with low IgE reactivity and retained T-cell reactivity show therapeutic promise.
    • Hypoallergenic major allergen forms have been successfully produced.
    • These modified allergens reduce IgE epitopes while maintaining protective response characteristics.

    Conclusions:

    • Hypoallergenic allergens are promising candidates for future allergen-specific immunotherapy.
    • Clinical trials are necessary to validate the safety and efficacy of these genetically engineered hypoallergens.
    • Safer vaccines are expected to improve patient compliance and increase immunotherapy use.